Capital Bank & Trust’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-240
Closed -$4K 728
2019
Q3
$4K Sell
240
-1,795
-88% -$29.2K ﹤0.01% 622
2019
Q2
$49K Hold
2,035
﹤0.01% 427
2019
Q1
$76K Hold
2,035
﹤0.01% 370
2018
Q4
$57K Sell
2,035
-14
-0.7% -$443 ﹤0.01% 403
2018
Q3
$81K Buy
2,049
+1,795
+707% +$78.5K ﹤0.01% 384
2018
Q2
$11K Hold
254
﹤0.01% 525
2018
Q1
$12K Hold
254
﹤0.01% 503
2017
Q4
$13K Buy
254
+14
+6% +$733 ﹤0.01% 536
2017
Q3
$12K Hold
240
﹤0.01% 497
2017
Q2
$9K Buy
+240
New +$9.47K ﹤0.01% 474

Other funds holding CC

Capital Bank & Trust's CC Position: Q4 2019 in Review

Capital Bank & Trust sold out of Chemours (CC) in Q4 2019, closing a stake of 240 shares — an estimated $4K sold.

Capital Bank & Trust first reported a position in CC in Q2 2017 and held it in 10 quarters. The position peaked at $81K in Q3 2018. 439 funds tracked by Wall St. Rank hold CC as of Q4 2019.

  • Capital Bank & Trust reported no remaining Chemours position as of Q4 2019 after selling out during the quarter.
  • Capital Bank & Trust sold 240 Chemours shares in Q4 2019, an estimated $4K.
  • Capital Bank & Trust first reported a position in Chemours in Q2 2017 and held it in 10 quarters.
  • Capital Bank & Trust's Chemours position peaked at $81K in Q3 2018.
  • 439 funds tracked by Wall St. Rank held Chemours as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.